164 results
Page 6 of 9
S-1
EX-10.39
9j4kos2z o3qvm0qqy
14 Oct 16
IPO registration
12:00am
S-1
EX-10.40
0g4acndluesdb u9p
14 Oct 16
IPO registration
12:00am
S-1
EX-10.35
udyphsk0hl5805cilj
14 Oct 16
IPO registration
12:00am
S-1
EX-10.36
wfrsvh7l4l
14 Oct 16
IPO registration
12:00am
DRS/A
EX-10.31
9pfb3je8ynlhtkur7yc
14 Oct 16
Draft registration statement (amended)
12:00am
S-1
EX-10.31
ifc590am
14 Oct 16
IPO registration
12:00am
DRS/A
EX-10.40
n1ikc5o pdd
14 Oct 16
Draft registration statement (amended)
12:00am
DRS/A
EX-10.38
hawb lnqrc
14 Oct 16
Draft registration statement (amended)
12:00am
S-1
EX-10.38
9ic09 aqrr1wyib9
14 Oct 16
IPO registration
12:00am
DRS/A
EX-10.36
l0t3tlacq
14 Oct 16
Draft registration statement (amended)
12:00am
DRS/A
EX-10.35
aq9zn05fz69ters4
14 Oct 16
Draft registration statement (amended)
12:00am
DRS/A
EX-10.39
eaxw8zj97 j3
14 Oct 16
Draft registration statement (amended)
12:00am
DRS/A
EX-10.35
d99uo9obpfg1mp166y
25 Aug 16
Draft registration statement (amended)
12:00am
DRS/A
EX-10.36
npy9079xal5cxx 867
25 Aug 16
Draft registration statement (amended)
12:00am
DRS/A
EX-10.31
4d82k0u gc1r07vl2cv
25 Aug 16
Draft registration statement (amended)
12:00am
8-K
EX-10.1
mkgyjvfywaalflp844
20 May 16
Other Events
12:00am
8-K
EX-10.1
hktr1amedbamud8p11
21 Apr 16
Immune Therapeutics signs Binding Letter of Intent to Acquire Chinese CAR-T Technology and Clinical Data
12:00am
8-K
EX-10.1
0wxfpolwfqezt8
4 Dec 15
Financial Statements and Exhibits
12:00am
8-K
EX-10.1
4srx9aan a0b1mtvdj8j
21 May 15
Entry into a Material Definitive Agreement
12:00am